Day: February 24, 2021

VANCOUVER, British Columbia, Feb. 24, 2021 (GLOBE NEWSWIRE) — AREV NANOTEC BRANDS INC. (CSE: AREV) (OTC: AREVF) (“AREV Nanotec” or “AREV”), is pleased to announce the addition of Kevin J. Phelps to its Board of Directors. Mr. Phelps has a long history in the biotechnology and drug discovery industries, currently serving as the CEO of Immune Therapeutics, Inc. (IMUN), a publicly-traded company focused on mid-stage immune-based therapies, and as Chairman of OyaGen, Inc., a privately-held early-stage drug development company dedicated to developing new therapeutics to address a variety of viral pathogens and oncological indications.AREV Nanotec CEO Mike Withrow stated, “I am excited to welcome Kevin Phelps to our Board of Directors. Our leadership is quickly maturing into one reflective of the expertise needed to advance new therapies...

$170,000 grants will fill critical gap for 3,000 food insecure families in Greater Boston via Food For Free’s new grocery box programCAMBRIDGE, Mass., Feb. 24, 2021 (GLOBE NEWSWIRE) — Life Science Cares Boston and the Biogen Foundation have teamed up as inaugural sponsors of Food For Free’s new Just Eats Grocery Box program, a $170,000 effort to reduce food insecurity for 3,000 area families, starting this month. To launch Just Eats, Life Science Cares, the life science industry platform for giving back, has committed $50,000, and the Biogen Foundation, the philanthropic arm of Cambridge-based neuroscience pioneer Biogen Inc. (Nasdaq: BIIB), has committed $100,000, matching the $50,000 from Life Science Cares and donating an additional $50,000 to combatting food insecurity for children in Greater Boston. Committing an additional...

VANCOUVER, British Columbia, Feb. 24, 2021 (GLOBE NEWSWIRE) — Gold Standard Ventures Corp. (NYSE AMERICAN: GSV) (TSX: GSV) (“Gold Standard” or the “Company”) announced today that Jason Attew, President and CEO, will present virtually at the BMO Global Metals & Mining Conference on Wednesday, March 3, 2021 at 3:30 p.m. ET.The presentation will be available on the “Investors” section of the Company’s website.About Gold StandardGold Standard is developing the South Railroad Project, an open pit, heap leach gold project located in Elko County, Nevada. The project is part of a +21,000 hectare land package on the Carlin Trend, and is 100% owned or controlled by Gold Standard. The goal of the Company is to become the low-cost junior producer of choice in Nevada, one of the premier mining jurisdictions in the world.For further information...

VANCOUVER, British Columbia, Feb. 24, 2021 (GLOBE NEWSWIRE) — WPD Pharmaceuticals (CSE:WBIO) (8SV1.F) (“WPD” or the “Company”) today announced that it has signed an agreement with CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) (“CNS”) to obtain Investigational Medicinal Product (“IMP”) for use in the planned clinical trials of Berubicin. WPD will purchase half of the batch previously manufactured for CNS by BSP Pharmaceuticals for the WPD-201 and WPD-201P studies which are planned to begin in the first half of 2021. This IMP will be QP certified by Clinigen Clinical Supplies Management on behalf of WPD under European current Good Manufacture Practice (“cGMP”) requirements.Berubicin is a novel anthracycline candidate for the treatment of a number of serious oncology indications including Glioblastoma Multiforme (GBM). WPD sublicensed...

ITI-1284 is a deuterated form of lumateperone delivered sublingually as an orally disintegrating tablet (ODT-SL). ITI-1284 ODT-SL may offer pharmacologic benefits and ease-of-use for patients, particularly in elderly populations.Phase 1 single ascending dose and multiple ascending dose studies have been completed in healthy volunteers including elderly subjects > than 65 years of age.Company plans to develop ITI-1284 for the treatment of behavioral disturbances in dementia, dementia-related psychosis, and certain depressive disorders in the elderly.NEW YORK, Feb. 24, 2021 (GLOBE NEWSWIRE) — Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced the expansion of its pipeline with ITI-1284...

TORONTO, Feb. 24, 2021 (GLOBE NEWSWIRE) — Gowest Gold Ltd. (“Gowest” or the “Company”) (TSX VENTURE: GWA) is pleased to provide an update on the processing of the first gold ore from the Company’s 100% owned Bradshaw Gold Deposit (“Bradshaw”).In late January 2021, Gowest successfully completed processing 23,000 tonnes of the gold-bearing mixed development, unclassified material (see Gowest release dated Dec. 9, 2020) stockpiled during the commencement of its bulk sample program at Bradshaw. The Company had planned to first process this unclassified gold-bearing material in order to gather valuable evidence of how it responds to ore-sorting, grinding, flotation, dewatering and concentrate smelting. This trial has also demonstrated that the mill site water quality and tailings impoundment were in regulatory compliance confirming that...

Reports quarterly revenue of $108.6 million, representing 56% year-over-year growth, and annual revenue of $366.3 million represents 36% year-over-year growthOrganic revenue growth was 47% for the fourth quarter and 29% for the year 2020WALTHAM, Mass., Feb. 24, 2021 (GLOBE NEWSWIRE) — Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today reported financial results for its fourth quarter and full year 2020. Provided in this press release are financial highlights for the three – and twelve-month periods ended December 31, 2020, followed by our current financial guidance for the year 2021, and access information for today’s webcast and conference call.Tony J. Hunt, President and Chief Executive Officer said, “We are delighted with the way we finished off 2020 with 47%...

TORONTO, Feb. 24, 2021 (GLOBE NEWSWIRE) — Troilus Gold Corp. (TSX: TLG; OTCQB: CHXMF) (“Troilus” or the “Company”) reports additional drill results from recent exploration drilling at its 100%-owned Troilus Gold Project (“Troilus” or the “Project”) located in north central Quebec, Canada. These latest results represent exploration and step out holes located in the Southwest Zone, a priority growth target which was discovered and drilled in late 2019 and early 2020 (See Figure 1). Results continue to define significant mineral expansion well beyond the pit proposed in the Preliminary Economic Assessment (“PEA”) (See press release dated August 31, 2020) (See Figure 2). Highlights include:ZSW20-209 extended known mineralization an additional 250 metres east of the PEA defined pit shell, over 225m below it and remains open, suggesting...

WILMETTE, Ill., Feb. 24, 2021 (GLOBE NEWSWIRE) — Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company primarily focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients, today announced that Chandler D. Robinson, MD, Chief Executive Officer, is planning to present a Company overview at the following investor conferences in March:H.C. Wainwright Global Life Sciences ConferenceThe Company’s presentation will be webcast on Tuesday, March 9, 2021 at 7:00 a.m. ET33rd Annual Roth Conference, HealthcareThe Company’s fireside chat will be webcast on Tuesday, March 16, 2021 at 12:00 p.m. ETMaxim’s 2021 Emerging Growth Virtual ConferencePresentation time to be determined on Wednesday, March 17, 2021About Monopar Therapeutics Inc.Monopar Therapeutics...